Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Characterization of human plasma pregnancy-associated miRNAs at first trimester and their association with pregnancy complications

ABSTRACT: Characterization of human plasma pregnancy-associated miRNAs at first trimester and their association with pregnancy complications

PROVIDER: PRJNA896544 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21999800.fastq.gz	Fastqsanger.gz
	SRR21999900.fastq.gz	Fastqsanger.gz
	SRR21999801.fastq.gz	Fastqsanger.gz
	SRR21999901.fastq.gz	Fastqsanger.gz
	SRR21999802.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 714

Similar Datasets

Characterization of human plasma pregnancy-associated miRNAs at first trimester and their association with pregnancy complications [cohort 1]

Project description:To characterize the human plasma microtranscriptome profile at first trimester of pregnancy in presence or not of pregnancy complications, we sequenced microRNAs in plasma samples collected from pregnant women between the 4th and the 16th weeks of pregnancy. We then performed differential expression analyses to assess the miRNA profile diffrences according to the presence of pregnancy complications or not (i.e. Gestational diabetes mellitus, Gestational hypertension or preeclampsia vs. normal pregnancies).

2022-10-24 | GSE216275 | GEO

Characterization of human plasma pregnancy-associated miRNAs at first trimester and their association with pregnancy complications [cohort 2]

Project description:To characterize the human plasma microtranscriptome profile at first trimester of pregnancy in presence or not of pregnancy complications, we sequenced microRNAs in plasma samples collected from pregnant women between the 6th and the 15th weeks of pregnancy as a replication cohort. We then performed differential expression analyses to assess the miRNA profile diffrences according to the presence of pregnancy complications or not (i.e. Gestational diabetes mellitus, Gestational hypertension or preeclampsia vs. normal pregnancies).

2022-11-03 | GSE216997 | GEO

Characterization of human plasma pregnancy-associated miRNAs at first trimester and their association with pregnancy complications [cohort 2]

Project description:Characterization of human plasma pregnancy-associated miRNAs at first trimester and their association with pregnancy complications [cohort 2]

| PRJNA896548 | ENA

Characterization of human plasma pregnancy-associated miRNAs at first trimester and their association with pregnancy complications [cohort 1]

Project description:Characterization of human plasma pregnancy-associated miRNAs at first trimester and their association with pregnancy complications [cohort 1]

| PRJNA892915 | ENA

Characterization of human plasma pregnancy-associated miRNAs at first trimester and their association with pregnancy complications

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-11-01 | GSE216998 | GEO

Circulating miRNAs in the first trimester and pregnancy complications: a systematic review.

Project description:Most pregnancy complications originate with early placentation. MicroRNAs (miRNAs) may play an important role in placentation and function as biomarkers of future pregnancy complications. We summarized from the literature all first trimester circulating miRNAs associated with pregnancy complications of placental origin and further identified the miRNAs which have the most evidence as potential early biomarkers for pregnancy complications. We conducted a systematic review following PRISMA reporting guidelines (PROSPERO CRD42020183421). We identified all first trimester serum or plasma miRNAs associated with a pregnancy complication of placental origin (preeclampsia, intrauterine growth restriction (IUGR), gestational hypertension, preterm delivery) and the number of times those miRNAs were identified, as a measure of replication. Twenty-one studies examined 118 unique miRNAs, and 87 were associated with at least one pregnancy complication; preeclampsia was the most common. Seven miRNAs were significantly associated with a pregnancy complication in at least two studies: miR-125b, miR-518b, miR-628-3p, miR-365a-3p, miR-520h, miR-374a-5p, miR-191-5p. Few miRNAs were associated with more than one pregnancy complication: miR-518b and miR-520h with preeclampsia and gestational hypertension, miR-374a-5p and miR-191-5p with preterm birth and preeclampsia. Our systematic review suggests seven miRNAs as potential biomarkers of pregnancy complications. These complications are thought to originate with early placental defects and these miRNAs may also be biomarkers of placental pathology. First-trimester biomarkers of pregnancy complications can facilitate early detection and interventions.

| S-EPMC9980650 | biostudies-literature

Prevalence of chromosomal alterations in first-trimester spontaneous pregnancy loss

Project description:Prevalence of chromosomal alterations in first-trimester spontaneous pregnancy loss

| PRJNA948396 | ENA

Investigating Human Placentation and Pregnancy Using First Trimester Chorionic Villi

Project description:Investigating Human Placentation and Pregnancy Using First Trimester Chorionic Villi

| PRJNA377795 | ENA

Prevalence of chromosomal alterations in first-trimester spontaneous pregnancy loss

Project description:Prevalence of chromosomal alterations in first-trimester spontaneous pregnancy loss

| PRJNA948399 | ENA

Prevalence of chromosomal alterations in first-trimester spontaneous pregnancy loss

Project description:Prevalence of chromosomal alterations in first-trimester spontaneous pregnancy loss